ÂÜÀòÂÒÂ×

Eric Block possesses extensive experience in oncology clinical development and medical affairs, currently serving as Clinical Program Lead at Boehringer Ingelheim since February 2015. Previous roles at Boehringer Ingelheim include Senior Associate Director and Associate Director in the field of oncology. Eric Block also held the position of Medical Science Liaison at Saladax Biomedical and held various roles, including Medical Director, at Grey Healthcare Group. Academic credentials include a PhD in Biomedical Sciences from New York University School of Medicine, with a focus on molecular oncology and immunology, and a BS in Biochemistry from Brown University.